The RBD pull-down results showed that overexpression of wild-type p190A in 293T cells decreased the amount of active RhoA compared with that in control cells and all endometrial cancer-associated p190A mutants, except p190A-S866F, showed impaired RhoGAP activities (Fig. 5a). Here, RHOA is linked to endometrial cancer.